WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'9801 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 17'1671 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 127'017  125'386  123'740  122'071  120'365  102'809  85'609  69'331 
Births 2'346  2'356  2'363  2'368  2'372  2'486  2'461  2'387 
Surviving infants 2'304  2'313  2'319  2'324  2'327  2'427  2'372  2'264 
Pop. less than 5 years 11'617  11'634  11'638  11'636  11'638  12'219  11'568  11'294 
Pop. less than 15 years 35'064  35'189  35'305  35'408  35'491  35'267  33'363  31'382 
Female 15-49 years 34'528  34'092  33'629  33'141  32'630  27'384  21'258  15'251 

Number of reported cases

(Click for retrospective incidence data for Mexico)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  30  68'782  29'730 
Mumps
ChartChart
  3'399  4'143  5'683  2'685  27'403 
Pertussis
ChartChart
  1'107  955  961  978  252  53  1'078  5'539 
Polio*
ChartChart
  682 
Rubella
ChartChart
  11'751 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  145 
Tetanus (total)**
ChartChart
  27  26  20  28  23  103  381  363 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mexico)
Vaccine year result method % card seen                                                
BCG 1986  73  DHS     99*  96  91  99  99  99*  67  48 
DTP1 1986  77  DHS     99*  89  99*  99 
DTP3 1986  34  DHS     87  87  83  99  97  97  53  44 
DTP4          88  85 
IPV1          99* 
HepB_BD          98  89  98 
HepB3          82  84  79  99  98  97 
Hib3          87  87  83  99  97  97 
JapEnc         
MCV1          99*  97  89  99  98  96  75  35 
MCV2          96  95  76  92  97  98 
PCV1          92  88  99 
PCV3          99*  94  84  99  98 
Pol3 1986  57  DHS     87  87  83  99  97  97  66  91 
Rota1          97  90  99 
RotaC          81  85  81  99  98 
Rubella1          99*  97  89  99  98 
TT2plus          22  99  78 
PAB         
VAD1          94  94  95 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mexico)
BCG
ChartChart
  96  96  91  99  99  99  67  48 
DTP1
ChartChart
  99  95  90  99  99  99  77  69 
DTP3
ChartChart
  87  87  83  99  97  97  53  44 
HepB3
ChartChart
  82  84  82  99  98  97 
HepB_BD
ChartChart
  98  90  82  90  98 
Hib3
ChartChart
  87  87  83  99  97  97 
IPV1
ChartChart
  99 
MCV1
ChartChart
  97  97  89  99  98  96  75  35 
MCV2
ChartChart
  96  95  76  92  97  98 
PAB
ChartChart
  90  88  88  88  88  81  59 
PCV3
ChartChart
  94  94  84  99  98 
Pol3
ChartChart
  87  87  83  99  97  97  66  91 
RCV1
ChartChart
  97  97  89  99  98  96 
RotaC
ChartChart
  81  85  81  99  98 

Number of districts in the country 2'457  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 60
From 80 to 89% 14
From 50 to 79% 22
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 18 months; Yes
DTwP 4 years; Yes
HPV 11 years (x2); Yes
HepA 1 year; Yes nurseries and childcare centers
HepB_Adult >=10 years; Yes risk groups not yet vaccinated
HepB_Pediatric birth; 2, 6 months; Yes
Influenza_Adult Yes Adults with chronic diseases, pregnant women, health care workers
Influenza_Pediatric < 5years; Yes and children with chronic diseases
MMR 1, 6 years; Yes
MR 11 years; Yes Not having received 2nd dose of MMR
OPV > 6 months - < 5 Years; Yes In February and May of each year
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >=50 years; Yes
Rotavirus 2, 4, 6 months; Yes
Td 10, 11-12 years; >12 years (x4) Yes and pregnant women
Tdap >12 years; Yes and pregnant women
Varicella 1 year; Yes risk groups and nurseries and childcare centers
VitaminA 6-59 months (x2); Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2018  2013-2018  2012-2018  2007-2012    2007-2010  2007-2012 
Nº of districts with microplans that include activities to raise immunization coverage number   32  236      236  236 

System performance

Total Nº districts in country number 2'456  2'440  2'432  2'456  2'438  2'438  2'438 
Nº districts with DTP3 coverage >=80% number 1'135    2'162      2'162  2'195 
% of districts with DTP3 coverage >=80% From 0 to 100% 46    89      89  90 
Nº districts with measles (MCV1) coverage >=95% number 1'260    2'031      2'031  2'053 
% of districts with MCV1 coverage >=95% From 0 to 100% 51    84      83  84 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100    100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.